By Cliff Gibbons, CanceRx Every day, promising life-saving cancer treatments stall in early-stage clinical development, where funding is scarce, timelines are long, and success rates are low. After a research institution, NIH/NCI comprehensive cancer center, or biotech company discovers a new cancer treatment, the drug must then go through rigorous, FDA-approved human testing — Phase…
